{"id":680677,"date":"2023-12-11T18:20:01","date_gmt":"2023-12-11T18:20:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=680677"},"modified":"2023-12-11T18:20:01","modified_gmt":"2023-12-11T18:20:01","slug":"asia-pacific-pharmacy-automation-market-worth-763-million-marketsandmarkets","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/asia-pacific-pharmacy-automation-market-worth-763-million-marketsandmarkets_680677.html","title":{"rendered":"Asia Pacific Pharmacy Automation Market worth $763 million | MarketsandMarkets"},"content":{"rendered":"
\n
\"Asia<\/a><\/div>\n
\n
Pharmacy automation systems minimize the risk of medication errors through precise dispensing, accurate labeling, and stringent quality checks, ensuring patients receive the correct medications in the right doses.<\/div>\n<\/div>\n<\/div>\n
In the near future, the Asia Pacific pharmacy automation industry is poised to undergo a transformative evolution, driven by rapid technological advancements and growing healthcare demands.<\/div>\n

Asia Pacific Pharmacy Automation Market<\/a><\/strong> in terms of revenue was estimated to be worth $496 million in 2023 and is poised to reach $763 million by 2028, growing at a CAGR of 9.0% from 2023 to 2028 according to a new report by MarketsandMarkets™.<\/p>\n

The increasing awareness among pharmacists, healthcare cost-reduction measures, and significant growth potential in emerging markets are some of the key factors that offer opportunities to the market during the forecast period. However, the stringent regulatory procedures, and the risk of cross-contamination are some of the factors challenging the market growth to some extent.<\/p>\n

Download an Illustrative overview: https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=78115984<\/a><\/strong><\/p>\n

Browse in-depth TOC on “Asia Pacific Pharmacy Automation Market”<\/strong><\/p>\n

150 – Tables<\/strong><\/p>\n

40 – Figures<\/strong><\/p>\n

200 – Pages<\/strong><\/p>\n

The automated packaging and labeling systems segment is expected to register a substantial growth in the Asia Pacific pharmacy automation market, by product <\/strong><\/p>\n

The automated packaging and labeling systems segment is expected to register a substantial growth in the Asia Pacific pharmacy automation market, by component. This growth can be attributed to increasing need to minimize medication errors, reduce labor costs, and increase productivity. The need to improve dispensing accuracy & productivity and lower the overall cost of the process is also a major driver for the automated packaging and labeling systems market.<\/p>\n

China is to witness a considerable growth rate during the forecast period.<\/strong><\/p>\n

The market in China is projected to grow at a considerable CAGR during the forecast period. Factors such as rising government initiatives, increasing medical tourism, growing government & private investments expected to bring about the creation of new market participants, growing emergence of various technologically advanced products are anticipated to drive the development of pharmacy automation applications in the China. Along with the abovementioned, the surging aging population, growing healthcare expenditure, urbanization & changing lifestyle, and the growth of e-commerce & online pharmacies will also help to bolster the growth of pharmacy automation market in China.<\/p>\n

Request Sample Pages: https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=78115984<\/a><\/strong><\/p>\n

Asia Pacific Pharmacy Automation Market Dynamics:<\/strong><\/p>\n

Drivers:<\/strong><\/p>\n

    \n
  1.  Technological advancements and integration with healthcare systems<\/li>\n<\/ol>\n

    Restraints:<\/strong><\/p>\n

      \n
    1.  Lack of skilled personnel<\/li>\n<\/ol>\n

      Opportunities:<\/strong><\/p>\n

        \n
      1.  Increasing awareness among pharmacists<\/li>\n<\/ol>\n

        Challenges:<\/strong><\/p>\n

          \n
        1.  Risk of cross-contamination<\/li>\n<\/ol>\n

          Key Market Players:<\/strong><\/p>\n

          Becton, Dickinson and Company (BD) (US), Yuyama Co., Ltd\/Yuyama Mfg Co., Ltd (Japan), Omnicell, Inc. (US), KUKA AG (Swisslog Healthcare) (Germany), TOSHO Co, Inc. (Japan), Oracle Corporation (US), TouchPoint Medical Solutions (US), Takazono Corporation (Japan), Capsa Healthcare (US), ARxIUM, Inc. (US), Mckesson Corporation (US), ATS Corporation (Canada), ScriptPro LLC (US), Hanmi Pharma Co., Ltd. (South Korea), NIHON CHOUZAI Co., Ltd. (Japan), and GETECH (Singapore) are the major players in this market. These companies are majorly focusing on the strategies such as agreements, collaborations, partnerships, and service launches in order to remain competitive and further increase their share in the market.<\/p>\n

          Get 10% Free Customization on this Report: https:\/\/www.marketsandmarkets.com\/requestCustomizationNew.asp?id=78115984<\/a><\/strong><\/p>\n

          Media Contact<\/span>
          Company Name:<\/strong>           MarketsandMarkets\u2122 Research Private Ltd.<\/a>
          Contact Person:<\/strong> Mr. Aashish Mehra
          Email:<\/strong>           Send Email<\/a>
          Phone:<\/strong> 18886006441
          Address:<\/strong>630 Dundee Road Suite 430
          City:<\/strong> Northbrook
          State:<\/strong> IL 60062
          Country:<\/strong> United States
          Website:<\/strong>           https:\/\/www.marketsandmarkets.com\/Market-Reports\/asia-pacific-pharmacy-automation-market-78115984.html<\/a><\/p>\n

          <\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

          Pharmacy automation systems minimize the risk of medication errors through precise dispensing, accurate labeling, and stringent quality checks, ensuring patients receive the correct medications in the right doses. In the near future, the Asia Pacific pharmacy automation industry is poised … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,403,404,416],"tags":[],"class_list":["post-680677","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/680677","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=680677"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/680677\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=680677"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=680677"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=680677"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}